X

Health Care

Eli Lilly (LLY) set to report Q2 2025 results. Here’s what to expect

Eli Lilly and Company (NYSE: LLY) had a positive start to fiscal 2025, reporting strong revenue and earnings growth for…

PFE Earnings: All you need to know about Pfizer’s Q2 2025 earnings results

Pfizer Inc. (NYSE: PFE) reported its second quarter 2025 earnings results today. Revenues were $14.7 billion, up 10% year-over-year. Reported…

Earnings Summary: IDEXX Q2 2025 profit rises on higher revenues

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a leading pet healthcare company, on Monday reported an increase in revenue and net income…

BIIB Earnings: Highlights of Biogen’s Q2 2025 results

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) on Thursday reported higher revenues and adjusted profit for the second quarter of 2025.…

Key highlights from AbbVie’s (ABBV) Q2 2025 earnings results

AbbVie (NYSE: ABBV) reported its second quarter 2025 earnings results today. Worldwide net revenues were $15.4 billion, up 6.6% on…

Bristol Myers Squibb (BMY) Earnings: 2Q25 Key Numbers

Bristol Myers Squibb (NYSE: BMY) reported its second quarter 2025 earnings results today. Total revenues inched up 1% year-over-year to…

MRK Earnings: Merck & Co Q2 adj. profit drops on lower sales

Merck & Co. Inc. (NYSE: MRK) on Tuesday reported lower sales and adjusted earnings for the second quarter of 2025.…

Key highlights from UnitedHealth Group’s (UNH) Q2 2025 earnings results

UnitedHealth Group (NYSE: UNH) reported its second quarter 2025 earnings results today. Total revenues were $111.6 billion compared to $98.8…

Earnings Summary: Revvity (RVTY) reports higher Q2 2025 revenues

Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, on Monday reported an increase in revenues for…

Earnings: A snapshot of Thermo Fisher Scientific’s (TMO) Q2 2025 report

Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader in life sciences, on Wednesday announced financial results for the second…

Abbott Laboratories (ABT) Q2 2025 sales and earnings beat estimates

Abbott Laboratories (NYSE: ABT) on Thursday announced financial results for the second quarter of fiscal 2025, reporting an increase in…

Key highlights from Johnson & Johnson’s (JNJ) Q2 2025 earnings results

Johnson & Johnson (NYSE: JNJ) reported its second quarter 2025 earnings results today. Reported sales increased 5.8% year-over-year to $23.7…

Johnson & Johnson to report Q2 earnings on July 16. Here’s what to expect

Johnson & Johnson's (NYSE: JNJ) business strategy for fiscal 2025 is focused on reducing the impact of patent expirations on…

Molina Healthcare reports preliminary Q2 2025 financial results

Molina Healthcare Inc. (NYSE: MOH), a managed care company focused on providing healthcare services to low-income individuals, on Monday reported preliminary…

Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials

Plus Therapeutics (NASDAQ: PSTV) is a pharmaceutical company engaged in the development of targeted radiotherapeutics for difficult-to-treat cancers. Currently, it…

Earnings Summary: CooperCompanies (COO) reports higher Q2 revenue and profit

Medical device maker CooperCompanies (NYSE: COO) has reported an increase in adjusted earnings for the second quarter of 2025, aided…

Hinge Health is all set to go public. What investors need to know

The IPO market has witnessed steady activity so far this year, despite fluctuations in momentum across months. The technology industry…

MDT Earnings: A snapshot of Medtronic’s Q4 2025 report

Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported higher revenues for the fourth quarter of 2025, which translated…

Earnings Summary: Henry Schein (HSIC) reports higher Q1 2025 profit

Henry Schein, Inc. (Nasdaq: HSIC), a provider of healthcare solutions to office-based dental and medical practitioners, Monday reported an increase in…

Earnings Summary: Cigna Group (CI) reports 14% growth in Q1 2025 revenue

The Cigna Group (NYSE: CI), a healthcare company focused on medical insurance and related services, reported results for the first quarter…

BIIB Earnings: Biogen Q1 2025 adj. profit drops despite higher revenues

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Thursday reported a year-over-year decrease in adjusted profit for the first quarter of 2025,…